IMM 3.51% 27.5¢ immutep limited

If I recall correctly, Marc Voigt's explanation was that IMM's...

  1. 15,518 Posts.
    lightbulb Created with Sketch. 43
    If I recall correctly, Marc Voigt's explanation was that IMM's clients are the pharma companies.
    He's always espoused the strategy that IMM would focus itself on trials and agency approval, whilst licensing the eventual product marketing to them.

    I've not heard anything from him or the company since that indicates that this business model has changed.

    The next 6 months or so look like they'll be pretty busy with trial data.
    Should be an interesting ride.

    .
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
27.5¢
Change
-0.010(3.51%)
Mkt cap ! $400.0M
Open High Low Value Volume
28.0¢ 28.3¢ 27.0¢ $1.034M 3.758M

Buyers (Bids)

No. Vol. Price($)
12 98156 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 85523 9
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.